Capecitabine-induced Dermatitis. Drug-induced dermatitis
Conditions
Interventions
Intervention 1: Group (1) Intervention: Patients with dermatitis will apply a topical medication consisting of violet oil in a sweet almond base daily for one month, using it in two doses (morning and
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Consent to Participate in the Study, Mental and Psychological Health, Patients with Cancer Undergoing Treatment with Capecitabine, Diagnosis of Anatomopathological Malignancies of Solid Organs, No Metastasis at the Time of Diagnosis, Age Range 18 to 65 Years, No Likely Use of Violet Oil, Topical Almond Oil, upon Entry into the Study, No Skin Diseases Including Lupus, Scleroderma, and Active Psoriasis, No Underlying Allergies, Diabetes, or Chronic Kidney Diseases No Use of Tobacco, Drugs, or Alcohol
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dermatitis. Timepoint: Zero day (the day before the intervention starts), days 15 and 30 after intervention, and two weeks after the end of the intervention. Method of measurement: CTCAE v5.0 form. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pruritis. Timepoint: Zero day (the day before the intervention starts), days 15 and 30 after intervention, and two weeks after the end of the intervention. Method of measurement: self-report.;Quality of life. Timepoint: Zero day (beginning of the study) and day 30 (end of the study). Method of measurement: DLQI questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadreza Ghanbarzadeh
Sabzevar University of Medical Sciences
Outcome results
None listed